Target Healthcare REIT’s (THRL) “Buy” Rating Reiterated at Jefferies Financial Group

Target Healthcare REIT (LON:THRL – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Jefferies Financial Group in a research note issued to investors on Thursday, Digital Look reports. They presently have a GBX 124 price objective on the stock. Jefferies Financial Group’s target price suggests a potential upside of 8.01% from the stock’s previous close.

Target Healthcare REIT Stock Performance

Shares of LON THRL traded up GBX 1.60 during trading hours on Thursday, hitting GBX 114.80. The stock had a trading volume of 27,026,324 shares, compared to its average volume of 4,791,200. The company has a market capitalization of £712.03 million, a P/E ratio of 8.62, a P/E/G ratio of 1.48 and a beta of 0.71. The firm’s 50-day moving average price is GBX 111.87 and its two-hundred day moving average price is GBX 109.06. Target Healthcare REIT has a 52 week low of GBX 92 and a 52 week high of GBX 117.

Target Healthcare REIT (LON:THRL – Get Free Report) last released its quarterly earnings data on Wednesday, September 23rd. The company reported GBX 13.32 EPS for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. As a group, analysts expect that Target Healthcare REIT will post 6.22 EPS for the current fiscal year.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

See Also

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.